Key result
Physiological pacing post-TAVR linked to ~43% lower risk of CV death or HF hospitalization vs RVP.
Its licence doesn't allow us to show a copy here.
Why the study?
Pacemaker implantation after TAVR is common and associated with adverse outcomes, and the comparative long-term effects of CPP versus RVP are unclear.
Does cardiac physiological pacing reduce the composite of cardiovascular death or heart failure hospitalization compared to right ventricular pacing in patients requiring permanent pacing after TAVR?
Cohort (n=932)
Yes
Does cardiac physiological pacing reduce the composite of cardiovascular death or heart failure hospitalization compared to right ventricular pacing in patients requiring permanent pacing after TAVR?
Hazard Ratio: 0.57 (95% CI 0.39–0.83)
Absolute Event Rate: 9.7% vs 17.6%
p-value: p=0.003
In patients requiring permanent pacemaker implantation following TAVR, cardiac physiological pacing is associated with a significantly lower risk of heart failure hospitalization compared to traditional right ventricular pacing.
Physiological pacing post-TAVR was associated with lower CV death or HF hospitalization; extends observational data but leaves open superiority over RV pacing in RCTs.
BACKGROUND Pacemaker implantation after transcatheter aortic valve replacement (TAVR) is common and has been associated with adverse clinical outcomes. Cardiac physiological pacing (CPP) may preserve ventricular synchrony and reduce heart failure (HF) events compared with right ventricular pacing (RVP). OBJECTIVES This study sought to compare long-term clinical outcomes of CPP vs RVP in patients requiring permanent pacing after TAVR. METHODS Registro de Estimulación Fisiológica-TAVR is a retrospective, multicenter nationwide registry including patients undergoing TAVR and pacemaker implantation within 30 days. Propensity score matching (1:1) was performed using baseline clinical and echocardiographic variables, yielding 466 matched pairs. The primary endpoint was the composite of cardiovascular death or HF hospitalization. Cox proportional hazards models were used for time-to-event analyses. Median follow-up was 24 months. RESULTS In the propensity score-matched cohort, CPP was associated with a lower incidence of the primary endpoint than RVP (9.7% vs 17.6%; HR: 0.57; 95% CI: 0.39-0.83; P = 0.003). This difference was driven by fewer HF hospitalizations (7.9% vs 13.9%; HR: 0.57; 95% CI: 0.37-0.86; P = 0.008). No significant differences were observed in cardiovascular death or all-cause mortality between groups. CONCLUSIONS In this multicenter propensity score-matched study, CPP after TAVR was associated with a lower risk of the primary endpoint, driven by fewer HF hospitalizations. These findings support the need for further randomized clinical trials to evaluate the role of CPP in post-TAVR patients requiring ventricular pacing.
No takes yet. Share an insight, caveat, or question.
Díez‐Delhoyo et al. (2026) conducted a cohort in Patients requiring permanent pacing after TAVR (n=932). Cardiac physiological pacing (CPP) vs. Right ventricular pacing (RVP) was evaluated on Composite of cardiovascular death or HF hospitalization (HR 0.57, 95% CI 0.39-0.83, p=0.003). Cardiac physiological pacing post-TAVR lowered the risk of cardiovascular death or HF hospitalization versus right ventricular pacing (9.7% vs 17.6%; HR 0.57; 95% CI 0.39-0.83; P=0.003).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: